Skip to content
← Full study record

NCT01823198 · MORE INFO

Limitations, agreements, and source contact

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies · Source last updated 2023-11-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rchampli@mdanderson.org
organization
University of Texas MD Anderson Cancer Center
phone
713-792-3618
title
Richard Champlin, MD / Stem Cell Transplantation Department
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rchampli@mdanderson.org
organization
University of Texas MD Anderson Cancer Center
phone
713-792-3618
title
Richard Champlin, MD / Stem Cell Transplantation Department

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice